COAGULATION
Unveiling the sthemO haemostasis solution with unique dual technology
Stago’s new high-throughput, fully automated coagulation analyser delivers precision, speed and productivity as demonstrated in recently published studies. The company has worked in blood-based diagnostics for over 60 years, becoming a preferred commercial partner to coagulation laboratory specialists.
Stago’s innovative approach to technology and testing which it has exhibited over the past decades continues with the launch of its next generation ‘sthem’ solutions. These offer a new range of haemostasis instruments and reagents to meet, even exceed, the current needs of the NHS coagulation testing service, both routine and specialist. Leading the way are new sthemO haemostasis analysers, the first example of which is being unveiled to the UK diagnostics community at this year’s IBMS Congress. The flagship sthemO 301 is a high-throughput, fully automated coagulation analyser for medium to large laboratories. “Precision, accuracy, speed and productivity are the standout features of the new sthemO 301,” says Yannig Querel, Business Unit Marketing Manager - UK. “Our new random-access analyser offers continuous loading with a capacity of 168 samples - providing a walkaway capacity that elevates productivity levels.”
Seamless track integration The sthemO 301 has been developed to be fully scalable and easily integrated
WWW.PATHOLOGYINPRACTICE.COM SEPTEMBER 2023
Stago’s sthemO 301 is the flagship of the company’s new range of sthemO haemostasis analysers, a high-throughput, fully automated coagulation analyser offering continuous loading with a capacity of 168 samples.
4
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41
